Injective (INJ) is currently trading at $6.06, up 12.91% for the day. The asset remains well above its 20-day, 50-day, and 200-day moving averages, reflecting strong bullish momentum and persistent strength toward session highs.
Highlights
- INJ/USD maintains strong bullish momentum, trading decisively above key short-, medium-, and long-term technical supports.
- Technical indicators signal robust buying pressure, though several oscillators warn of emerging overbought conditions and pullback risk.
- Expected trading range over the next five sessions is $5.34 to $6.54, with sideways consolidation likely unless a breakout or reversal occurs.
Technical support and momentum reinforced by multi-timeframe alignment
INJ/USD is trading well above its 20-day, 50-day, and 200-day moving averages, all of which indicate clear support at $5.02, $4.07, and $4.25 respectively. This alignment confirms bullish momentum across short-, medium-, and long-term timeframes, with immediate dynamic support at the Ichimoku Kijun level of $4.89; potential resistance now stands at the next major round level, as the price has exceeded MA-50.
Earlier, analysts noted that Injective was sustaining its bullish trajectory, supported by robust momentum even amid signals of potential overbought conditions and technical uncertainty. With the asset now decisively extending gains and technical indicators delivering mixed signals, traders should monitor for a breakout above $6.54 or a drop below $5.34 as catalysts for renewed volatility in the coming sessions.
Latest Injective News
- Forex
- Crypto